Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

32.0%

8 terminated/withdrawn out of 25 trials

Success Rate

61.9%

-24.6% vs industry average

Late-Stage Pipeline

12%

3 trials in Phase 3/4

Results Transparency

77%

10 of 13 completed trials have results

Key Signals

1 recruiting10 with results6 terminated

Enrollment Performance

Analytics

N/A

10(50.0%)

Phase 2

6(30.0%)

Phase 4

3(15.0%)

Early Phase 1

1(5.0%)

20Total

N/A(10)

Phase 2(6)

Phase 4(3)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials

NCT07022418Phase 2Recruiting

Formoterol in Diabetes

Role: collaborator

NCT02933151Not ApplicableCompleted

Health Effects of oraL Protein Supplements in HD (The HELPS-HD Trial)

Role: lead

NCT02593526Not ApplicableTerminated

Diuretic/Cool Dialysate Trial

Role: collaborator

NCT02628366Not ApplicableCompleted

Major Outcomes With Personalized Dialysate TEMPerature

Role: collaborator

NCT02182089Unknown

Measuring Cardiovascular Stress in Patients on Hemodialysis Study II

Role: collaborator

NCT04780698Not ApplicableCompleted

DCI COVID-19 Surveillance Project

Role: collaborator

NCT02433210Not ApplicableCompleted

A Clinical Study Comparing Basic Performance and Hemocompatibility of 3 Different Dialyzers in Hemodialysis Patients

Role: collaborator

NCT00293202Phase 2Terminated

Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients

Role: collaborator

NCT02755818Terminated

Study of the Relationship Between Body Composition, Insulin Resistance and HDL Levels

Role: collaborator

NCT04020757Phase 2Terminated

H+ Mobilization With Dialysate Bicarbonate Variation

Role: collaborator

NCT03144817Phase 2Completed

Dialysate Sodium Lowering Trial

Role: collaborator

NCT01230489Not ApplicableTerminated

The Efficacy of "MediHoney" to Facilitate Catheter Exit-Site Surgical Wound Healing

Role: collaborator

NCT02627118Not ApplicableCompleted

Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H

Role: collaborator

NCT01804777Early Phase 1Terminated

Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes

Role: collaborator

NCT03106948Phase 2Unknown

Delivery of Inhibitors of Lysyl Oxidase (LysoLox) on Serial Angioplasty and Time to Restenosis

Role: collaborator

NCT00583973Completed

Effect of Parenteral Iron Therapy on Inflammatory Response and Oxidative Stress Chronic Hemodialysis

Role: collaborator

NCT00938561Withdrawn

Evaluation of New Markers to Assess Kidney Function

Role: collaborator

NCT00286403Phase 2Withdrawn

Vasodilators and Anti-Oxidant Therapy in Early ATN

Role: collaborator

NCT01395823Phase 4Completed

Safety and Effects of Supplementation With Ergocalciferol on Erythropoietin Dosing in Hemodialysis Patients

Role: lead

NCT02100462Phase 4Unknown

Chlorthalidone and HCTZ Impacts on Platelet Activation

Role: collaborator